Pages that link to "Q50142293"
Jump to navigation
Jump to search
The following pages link to Cost analysis of the treatment of severe spinal spasticity with a continuous intrathecal baclofen infusion system (Q50142293):
Displaying 8 items.
- A benefit-risk assessment of baclofen in severe spinal spasticity. (Q33981151) (← links)
- The medical management of spasticity (Q34579714) (← links)
- Intrathecal baclofen pump for spasticity: an evidence-based analysis (Q36056214) (← links)
- Neuromodulation for spasticity and dystonia (Q43473646) (← links)
- Implantable Baclofen Pump as an Adjuvant in Treatment of Pressure Sores (Q43650494) (← links)
- Cost impact of intrathecal polyanalgesia (Q43763677) (← links)
- Cost-effectiveness comparison of tizanidine and baclofen in the management of spasticity (Q44140568) (← links)
- Burden of disease in multiple sclerosis patients with spasticity in Germany: mobility improvement study (Move I). (Q48125672) (← links)